Advertisement
Research Article| Volume 183, P76-81, March 15, 2015

Download started.

Ok

Efficacy and survival in patients with cardiac contractility modulation: Long-term single center experience in 81 patients

  • Author Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Jürgen Kuschyk
    Correspondence
    Corresponding author at: University Medical Centre, I. Medical Department, Theodor-Kutzer-Ufer 1-3, 68167 Mannheim, Germany.
    Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Affiliations
    University Medical Centre, I. Medical Department, Mannheim, Germany
    Search for articles by this author
  • Author Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Susanne Roeger
    Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Affiliations
    University Medical Centre, I. Medical Department, Mannheim, Germany
    Search for articles by this author
  • Author Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Raphaela Schneider
    Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Affiliations
    University Medical Centre, I. Medical Department, Mannheim, Germany
    Search for articles by this author
  • Author Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Florian Streitner
    Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Affiliations
    University Medical Centre, I. Medical Department, Mannheim, Germany
    Search for articles by this author
  • Author Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Ksenija Stach
    Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Affiliations
    University Medical Centre, I. Medical Department, Mannheim, Germany
    Search for articles by this author
  • Author Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Boris Rudic
    Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Affiliations
    University Medical Centre, I. Medical Department, Mannheim, Germany
    Search for articles by this author
  • Author Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Christel Weiß
    Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Affiliations
    University Medical Centre, Institute for Medical Statistics, Mannheim, Germany
    Search for articles by this author
  • Author Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Rainer Schimpf
    Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Affiliations
    University Medical Centre, I. Medical Department, Mannheim, Germany
    Search for articles by this author
  • Author Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Theano Papavasilliu
    Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Affiliations
    University Medical Centre, I. Medical Department, Mannheim, Germany
    Search for articles by this author
  • Author Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Benny Rousso
    Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Affiliations
    IMPULSE Dynamics, Orangeburg, NY, USA
    Search for articles by this author
  • Author Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Daniel Burkhoff
    Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Affiliations
    Columbia University, Cardiology, NY, USA
    Search for articles by this author
  • Author Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Martin Borggrefe
    Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
    Affiliations
    University Medical Centre, I. Medical Department, Mannheim, Germany
    Search for articles by this author
  • Author Footnotes
    1 The authors take responsibility for all aspects of the reliability and freedom from bias of the data presented and their discussed interpretation. There is no acknowledgement of grant support to declare.
Published:January 20, 2015DOI:https://doi.org/10.1016/j.ijcard.2014.12.178

      Abstract

      Aims

      To analyze long-term efficacy and survival in patients with chronic heart failure treated with cardiac contractility modulation.

      Methods

      81 patients implanted with a CCM device between 2004 and 2012 were included in this retrospective analysis. Changes in NYHA class, ejection fraction (EF), Minnesota Living with Heart Failure Questionnaire, NT-proBNP and peak VO2 were analyzed during a mean follow up of 34.2 ± 28 months (6–123 months). Observed mortality rate was compared with that predicted by the MAGGIC Score.

      Results

      Patients were 61 ± 12 years old with EF 23 ± 7%. Heart failure was due to ischemic (n = 48, 59.3%) or idiopathic dilated (n = 33, 40.7%) cardiomyopathy. EF increased from 23.1 ± 7.9 to 29.4 ± 8.6% (p < 0.05), mean NT-proBNP decreased from 4395 ± 3818 to 2762 ± 3490 ng/l (p < 0.05) and mean peak VO2 increased from 13.9 ± 3.3 to 14.6 ± 3.5 ml/kg/min (p = 0.1). The overall clinical responder rate (at least 1 class improvement of NYHA within 6 months or last follow-up) was 74.1%. 21 (25.9%) patients died during follow up, 11 (52.4%) due to cardiac conditions and 10 (47.6%) due to non-cardiac conditions. Mortality rates at 1 and 3 years were 5.2% and 29.5% compared to mortality rates estimated from the MAGGIC risk score of 18.4% (p < 0.001) and 40% (p = ns), respectively. Log-Rank analysis of all events through 3 years of follow-up, however, was significantly less than predicted (p = 0.022).

      Conclusions

      CCM therapy improved quality of life, exercise capacity, NYHA class, EF and NT-proBNP levels during long-term follow up. Mortality rates appeared to be lower than estimated from the MAGGIC score.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to International Journal of Cardiology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Bristow M.R.
        • Saxon L.A.
        • Boehmer J.
        • Krueger S.
        • Kass D.A.
        • De Marco T.
        • et al.
        Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure.
        N. Engl. J. Med. 2004; 350: 2140-2150
        • Cleland J.G.
        • Daubert J.C.
        • Erdmann E.
        • Freemantle N.
        • Gras D.
        • Kappenberger L.
        • et al.
        The effect of cardiac resynchronization on morbidity and mortality in heart failure.
        N. Engl. J. Med. 2005; 352: 1539-1549
        • Abraham W.T.
        • Fisher W.G.
        • Smith A.L.
        • Delurgio D.B.
        • Leon A.R.
        • Loh E.
        • et al.
        Cardiac resynchronization in chronic heart failure.
        N. Engl. J. Med. 2002; 346: 1845-1853
        • Beshai J.F.
        • Grimm R.A.
        • Nagueh S.F.
        • Baker II, J.H.
        • Beau S.L.
        • Greenberg S.M.
        • et al.
        Cardiac-resynchronization therapy in heart failure with narrow QRS complexes.
        N. Engl. J. Med. 2007; 357: 2461-2471
        • Ruschitzka F.
        • Abraham W.T.
        • Singh J.P.
        • Bax J.J.
        • Borer J.S.
        • Brugada J.
        • et al.
        Cardiac-resynchronization therapy in heart failure with a narrow QRS complex.
        N. Engl. J. Med. 2013; 369: 1395-1405
        • Brignole M.
        • Auricchio A.
        • Baron-Esquivias G.
        • Bordachar P.
        • Boriani G.
        • Breithardt O.A.
        • et al.
        ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA).
        Eur. Heart J. 2013; 34: 2281-2329
        • Borggrefe M.
        • Burkhoff D.
        Clinical effects of cardiac contractility modulation (CCM) as a treatment for chronic heart failure.
        Eur. J. Heart Fail. 2012; 14: 703-712
        • Borggrefe M.M.
        • Lawo T.
        • Butter C.
        • Schmidinger H.
        • Lunati M.
        • Pieske B.
        • et al.
        Randomized, double blind study of non-excitatory, cardiac contractility modulation electrical impulses for symptomatic heart failure.
        Eur. Heart J. 2008; 29: 1019-1028
        • Kadish A.
        • Nademanee K.
        • Volosin K.
        • Krueger S.
        • Neelagaru S.
        • Raval N.
        • et al.
        A randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure.
        Am. Heart J. 2011; 161 (e1-2): 329-337
        • Schau T.
        • Seifert M.
        • Meyhofer J.
        • Neuss M.
        • Butter C.
        Long-term outcome of cardiac contractility modulation in patients with severe congestive heart failure.
        Europace. 2011; 13: 1436-1444
        • Yu C.M.
        • Chan J.Y.
        • Zhang Q.
        • Yip G.W.
        • Lam Y.Y.
        • Chan A.
        • et al.
        Impact of cardiac contractility modulation on left ventricular global and regional function and remodeling.
        J. Am. Coll. Cardiol. Img. 2009; 2: 1341-1349
        • Pocock S.J.
        • Ariti C.A.
        • McMurray J.J.
        • Maggioni A.
        • Kober L.
        • Squire I.B.
        • et al.
        Predicting survival in heart failure: a risk score based on 39 372 patients from 30 studies.
        Eur. Heart J. 2013; 34: 1404-1413
        • Abraham W.T.
        • Nademanee K.
        • Volosin K.
        • Krueger S.
        • Neelagaru S.
        • Raval N.
        • et al.
        Subgroup analysis of a randomized controlled trial evaluating the safety and efficacy of cardiac contractility modulation in advanced heart failure.
        J. Card. Fail. 2011; 17: 710-717
        • Roger S.
        • Schneider R.
        • Rudic B.
        • Liebe V.
        • Stach K.
        • Schimpf R.
        • et al.
        Cardiac contractility modulation: first experience in heart failure patients with reduced ejection fraction and permanent atrial fibrillation.
        Europace. 2014; 16: 1205-1209
        • Kuck K.H.
        • Bordachar P.
        • Borggrefe M.
        • Boriani G.
        • Burri H.
        • Leyva F.
        • et al.
        New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association.
        Europace. 2014; 16: 109-128
        • Kwong J.S.
        • Sanderson J.E.
        • Yu C.M.
        Cardiac contractility modulation for heart failure: a meta-analysis of randomized controlled trials.
        Pacing Clin. Electrophysiol. 2012; 35: 1111-1118
        • Giallauria F.
        • Vigorito C.
        • Piepoli M.F.
        • Stewart Coats A.J.
        Effects of cardiac contractility modulation by non-excitatory electrical stimulation on exercise capacity and quality of life: an individual patient's data meta-analysis of randomized controlled trials.
        Int. J. Cardiol. 2014; 175: 352-357
        • Butter C.
        • Meyhofer J.
        • Seifert M.
        • Neuss M.
        • Minden H.H.
        First use of cardiac contractility modulation (CCM) in a patient failing CRT therapy: clinical and technical aspects of combined therapies.
        Eur. J. Heart Fail. 2007; 9: 955-958
        • Nagele H.
        • Behrens S.
        • Eisermann C.
        Cardiac contractility modulation in non-responders to cardiac resynchronization therapy.
        Europace. 2008; 10: 1375-1380